Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD

A population pharmacokinetic analysis was conducted from a subset of samples obtained from the Lung Function and Quality of Life Assessment in Chronic Obstructive Pulmonary Disease with Closed Triple Therapy trial to characterize the pharmacokinetics of fluticasone furoate, umeclidinium, and vilante...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rashmi, Pefani, Eleni, Beerahee, Misba, Brealey, Noushin, Barnacle, Helen, Birk, Ruby, Zhu, Chang‐Qing, Lipson, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Pharmacometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175098/
https://www.ncbi.nlm.nih.gov/pubmed/29762864
http://dx.doi.org/10.1002/jcph.1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175098/
https://www.ncbi.nlm.nih.gov/pubmed/29762864
http://dx.doi.org/10.1002/jcph.1253

Ejemplares similares